Evaluation of the Efficacy of Doxycycline, Ciprofloxacin, Levofloxacin, and Co-trimoxazole Using
Coxiella
Q fever
antibiotic
treatment
Journal
Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061
Informations de publication
Date de publication:
18 10 2021
18 10 2021
Historique:
pubmed:
10
8
2021
medline:
3
11
2021
entrez:
9
8
2021
Statut:
ppublish
Résumé
Q fever, caused by the intracellular pathogen Coxiella burnetii, is traditionally treated using tetracycline antibiotics, such as doxycycline. Doxycycline is often poorly tolerated, and antibiotic-resistant strains have been isolated. In this study, we have evaluated a panel of antibiotics (doxycycline, ciprofloxacin, levofloxacin, and co-trimoxazole) against C. burnetii using
Identifiants
pubmed: 34370577
doi: 10.1128/AAC.00673-21
pmc: PMC8522727
doi:
Substances chimiques
Anti-Bacterial Agents
0
Ciprofloxacin
5E8K9I0O4U
Levofloxacin
6GNT3Y5LMF
Trimethoprim, Sulfamethoxazole Drug Combination
8064-90-2
Doxycycline
N12000U13O
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0067321Subventions
Organisme : MOD | Defence Science and Technology Laboratory (Dstl)
Références
J Antimicrob Chemother. 1999 Mar;43(3):345-9
pubmed: 10223589
Antimicrob Agents Chemother. 2001 Nov;45(11):3276-8
pubmed: 11600400
BMC Infect Dis. 2012 Dec 19;12:359
pubmed: 23249469
J R Army Med Corps. 2011 Jun;157(2):150-5
pubmed: 21805764
Front Cell Infect Microbiol. 2014 Dec 15;4:172
pubmed: 25566510
Antimicrob Agents Chemother. 1987 Jul;31(7):1079-84
pubmed: 3662472
Euro Surveill. 2012 Jan 19;17(3):20058
pubmed: 22297100
Australas Ann Med. 1962 Aug;11:184-8
pubmed: 13985830
Infection. 2010 Dec;38(6):471-7
pubmed: 20857313
Comp Med. 2013;63(6):469-76
pubmed: 24326221
Arch Intern Med. 2002 Mar 25;162(6):701-4
pubmed: 11911725
Antimicrob Agents Chemother. 1991 Oct;35(10):2070-7
pubmed: 1759829
J Bacteriol. 1956 Aug;72(2):235-41
pubmed: 13366905
Expert Rev Anti Infect Ther. 2013 Nov;11(11):1207-14
pubmed: 24073941
Antimicrob Agents Chemother. 2014 Sep;58(9):5510-8
pubmed: 25001305
Antimicrob Agents Chemother. 2001 Jan;45(1):301-2
pubmed: 11120982
Sex Transm Dis. 2002 Sep;29(9):497-502
pubmed: 12218839
Infect Immun. 2007 Sep;75(9):4263-71
pubmed: 17606599
Int J Antimicrob Agents. 2018 May;51(5):806-808
pubmed: 28802854
Br J Pharmacol. 2009 Jul;157(6):907-21
pubmed: 19508398
Lancet. 2006 Feb 25;367(9511):679-88
pubmed: 16503466
J Antimicrob Chemother. 2006 Aug;58(2):256-65
pubmed: 16816396
Egypt J Immunol. 2015;22(1):79-85
pubmed: 26415375
J Infect Chemother. 2018 Jun;24(6):470-475
pubmed: 29615379
J Infect. 2007 Apr;54(4):313-8
pubmed: 17147957
J Antimicrob Chemother. 1997 Jun;39(6):725-30
pubmed: 9222041
Euro Surveill. 2013 Jun 13;18(24):
pubmed: 23787163
FEMS Immunol Med Microbiol. 2012 Feb;64(1):3-12
pubmed: 22066649
Int J Antimicrob Agents. 2004 Feb;23(2):169-74
pubmed: 15013043
J Clin Microbiol. 2014 May;52(5):1637-43
pubmed: 24599987
Int J Antimicrob Agents. 2014 Mar;43(3):254-61
pubmed: 24361354
Microbiology (Reading). 2014 Jun;160(Pt 6):1175-1181
pubmed: 24677067
Am J Physiol. 1947 Jul 1;150(1):70-7
pubmed: 20252828
PLoS One. 2010 Jan 13;5(1):e8668
pubmed: 20084270
Int J Antimicrob Agents. 2013 Apr;41(4):330-6
pubmed: 23402703
Arch Intern Med. 1999 Jan 25;159(2):167-73
pubmed: 9927100
Trans Assoc Am Physicians. 1956;69:98-104
pubmed: 13380951
Sci Rep. 2019 Dec 2;9(1):18132
pubmed: 31792307
Infection. 2005 Dec;33 Suppl 2:55-70
pubmed: 16518713
Front Microbiol. 2019 Jul 16;10:1552
pubmed: 31379760
Int Immunopharmacol. 2014 Jan;18(1):27-34
pubmed: 24239744
Commun Dis Rep CDR Rev. 1996 Aug 16;6(9):R128-32
pubmed: 8810119
Infect Immun. 2000 Jul;68(7):3815-21
pubmed: 10858189
Int J Antimicrob Agents. 2011 Sep;38(3):249-56
pubmed: 21764262
J Immunol. 2002 Oct 15;169(8):4488-95
pubmed: 12370385
J Infect Dis. 2009 Aug 1;200(3):390-8
pubmed: 19563257
Clin Infect Dis. 2007 Sep 1;45(5):548-55
pubmed: 17682987